chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: RAB
Symptoms: Amnesia, Anxiety, Confusional state, Dizziness, Incomplete course of vaccination
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of nausea in a 34-year-old female patient who received RABAVERT. Co-suspect products included RABAVERT. Concurrent medical conditions included cat scratch. Concomitant products included RABAVERT. On 25th December 2016, the patient received the 2nd dose of RABAVERT. On an unknown date, the patient received the 5th dose of RABAVERT. On 26th December 2016, 1 days after receiving RABAVERT and not applicable after receiving RABAVERT, the patient experienced nausea. On 27th December 2016, the patient experienced panic attack, memory loss, felt faint, confusion and anxiety. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the nausea, panic attack, memory loss, confusion and anxiety were recovering/resolving and the outcome of the felt faint was recovered/resolved and the outcome of the incomplete course of vaccination was unknown. The reporter considered the nausea, panic attack, memory loss, felt faint, confusion and anxiety to be related to RABAVERT. Additional details were provided as follows: This was post exposure prophylaxis case of RABAVERT. This case was previously reported to a doctor. The reporter (the patient herself) got scratched by cat about 2 weeks prior to returning home. Once she came back to home, she contacted her physician who advised her to go to local emergency room where she received 4 doses of RABAVERT along with Immunoglobulin. On 22 December 2016, the patient received 1st dose of RABAVERT (batch number: 588011AA, expiry date: April 2019). The lot number of the 1st vaccine was provided from the box she was given with the 1st vaccine. On 25th December 2016, the patient received the 2nd dose of RABAVERT and experienced nausea, panic attack, memory loss, faint feeling, light headed, confusion and anxiety. On 29th December 2016 and 5th January 2017, the patient received 3rd and 4th doses of RABAVERT respectively. The patient denied any other medications being taken. The reporter noted most of the adverse events had improved to just sporadically occurring, but the light headed and faint feeling appear to have resolved. The reporter was seeking assistance with payment noting high deductible, she was provided Vaccine Reimbursement Support line number.
Age: 34.0
Sex: F
Vaccine: RAB
Symptoms: Nausea, Panic attack
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of nausea in a 34-year-old female patient who received RABAVERT. Co-suspect products included RABAVERT. Concurrent medical conditions included cat scratch. Concomitant products included RABAVERT. On 25th December 2016, the patient received the 2nd dose of RABAVERT. On an unknown date, the patient received the 5th dose of RABAVERT. On 26th December 2016, 1 days after receiving RABAVERT and not applicable after receiving RABAVERT, the patient experienced nausea. On 27th December 2016, the patient experienced panic attack, memory loss, felt faint, confusion and anxiety. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the nausea, panic attack, memory loss, confusion and anxiety were recovering/resolving and the outcome of the felt faint was recovered/resolved and the outcome of the incomplete course of vaccination was unknown. The reporter considered the nausea, panic attack, memory loss, felt faint, confusion and anxiety to be related to RABAVERT. Additional details were provided as follows: This was post exposure prophylaxis case of RABAVERT. This case was previously reported to a doctor. The reporter (the patient herself) got scratched by cat about 2 weeks prior to returning home. Once she came back to home, she contacted her physician who advised her to go to local emergency room where she received 4 doses of RABAVERT along with Immunoglobulin. On 22 December 2016, the patient received 1st dose of RABAVERT (batch number: 588011AA, expiry date: April 2019). The lot number of the 1st vaccine was provided from the box she was given with the 1st vaccine. On 25th December 2016, the patient received the 2nd dose of RABAVERT and experienced nausea, panic attack, memory loss, faint feeling, light headed, confusion and anxiety. On 29th December 2016 and 5th January 2017, the patient received 3rd and 4th doses of RABAVERT respectively. The patient denied any other medications being taken. The reporter noted most of the adverse events had improved to just sporadically occurring, but the light headed and faint feeling appear to have resolved. The reporter was seeking assistance with payment noting high deductible, she was provided Vaccine Reimbursement Support line number.
Age: 0.2
Sex: M
Vaccine: DTAP
Symptoms: Antibody test negative, Therapy non-responder
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of therapy non-responder in a 2-year-male patient who received DTaP vaccine. Co-suspect products included DTaP vaccine and DTaP vaccine. On an unknown date, the patient received the 1st dose of DTaP vaccine, the 2nd dose of DTaP vaccine and the 3rd dose of DTaP vaccine. On 30th January 2017, 1 year and 322 days after receiving DTaP vaccine, 1 year and 261 days after receiving DTaP vaccine and 1 year and 200 days after receiving DTaP vaccine, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown. It was unknown if the reporter considered the therapy non-responder to be related to DTaP vaccine, DTaP vaccine and DTaP vaccine. Additional details were provided as follows: The mother of the patient stated that, the patient received DTaP vaccine at 2, 4 and 6 months of age. On 30th January 2017, the patient underwent a serology test which revealed zero antibody titers. This led to a patient to be a therapy non responder. The reporter did not want to fill out the report while on the phone.
Age: 50.0
Sex: M
Vaccine: MNQ
Symptoms: Headache
Clinical narrative: Headache for 3 days following shot on 1/23/17. MENACTRA given. (Had previously in 1984). Employee notified us of H/A on 1/30/17 when came to office for Tdap shot.
Age: 72.0
Sex: M
Vaccine: PPV
Symptoms: Immediate post-injection reaction, Inflammation, Swelling
Clinical narrative: Localized inflammation occurred immediately after injection. Swelling did dissipate within 10 minutes. Patient was monitored for systemic reaction but no further reaction occurred and no further treatment was necessary. Patient was monitored for generalized reactions and none were observed.
Age: 68.0
Sex: F
Vaccine: FLU3, PNC13, TDAP, VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Patient states she experienced left arm swelling, itching and redness at injection site
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Induration, Injection site erythema, Injection site pain, Injection site pruritus, Skin warm
Clinical narrative: 4 in x 4 1/2 in induration; warm to touch. Red, itchy and painful site. All localized.
Age: 24.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Pruritus, Skin burning sensation, Skin irritation, Swelling
Clinical narrative: Vaccine given 2/6/17 at approximately 0800. Irritation began that evening with itching. The next day red, swollen and itchy. When scratched - burning. No relief with hydrocortisone. Today it has gotten bigger.
Age: 13.0
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Dry skin, Erythema, Rash, Rash erythematous, Rash macular
Clinical narrative: After receiving immunization, pt. broke out in blotchy red rash B/L arms. Rash was raised and rough like sandpaper. Denies itchiness, difficulty breathing or swallowing. Face red and blotchy. Given BENADRYL in office.
Age: 13.0
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Dry skin, Erythema, Rash erythematous, Rash macular
Clinical narrative: After receiving immunization, pt. broke out in blotchy red rash B/L arms. Rash was raised and rough like sandpaper. Denies itchiness, difficulty breathing or swallowing. Face red and blotchy. Given BENADRYL in office.
Age: 1.33
Sex: M
Vaccine: VARCEL
Symptoms: Erythema, Rash macular, Urticaria
Clinical narrative: About 1 hr after receiving vaccine, presented back in office w/hives on face, red blotchy spot on right side of face, another slightly raised spot on chin. Small red spot under left eye. Some fading already, gave BENADRYL.
Age: 2.0
Sex: M
Vaccine: IPV
Symptoms: Injection site pruritus, Injection site rash, Injection site warmth
Clinical narrative: Rash at site of injection - spreading down leg - hot and itchy. Recommended ice to leg and BENADRYL for itchiness.
Age: 0.33
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Dyskinesia, Tic
Clinical narrative: Tics/abn motor movements.
Sex: M
Vaccine: FLUX
Symptoms: Fatigue
Clinical narrative: Case number PHHY2015US161336, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 587632) website on 24 Nov 2015. This medically confirmed health authority (initial receipt: 537914). This report refers to a 52 years old male patient. Past medical history included as mild reactive airway disease (RAD), intermittent asthma (x12 years), actinic keratosis, suspected glaucoma (in 2011, the patient was unclear with the exact nature of this ocular condition which was followed annually), herpes zoster ophthalmicus (17 Oct 2011) involving lesions on left side of his face, eyelid and left side of his scalp, chicken pox (when he was three month old), male pattern baldness (stated that his hair were thinning) and benign lipoma right shoulder (in Sep 2011). Concomitant medication included as PROVENTIL. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 24 May 2013. On an unknown date, about 10 days after vaccination, the patient experienced fatigue which lasted for about 02 weeks. The patient was visited to the ER. On 13 Sep 2013, the patient received AFLURIA (batch number: 08649211A) into right arm intramuscular (refer to case 2014045233). The outcome of the event was reported as complete recovery on an unknown date. The seriousness of the event was reported as non-serious. The causality of the event was not reported.
Sex: M
Vaccine: FLU3
Symptoms: Headache, Myalgia, Nasal congestion, Oropharyngeal pain, Pain
Clinical narrative: Case number PHHY2016US011505 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 603435) website on 18 Jan 2016. This report refers to a 37 year old male patient. Medical history and concomitant medication were not reported. The patient was vaccinated with AGRIFLU (batch number: 174084) intramuscularly in the left arm on 10 Oct 2015. On 16 Oct 2015 the patient experienced sore throat, body pain, nasal congestion, cough with expectoration, myalgia and headache. Outcome of the events was reported as complete recovery. Seriousness of the events was reported as non serious and causality was not reported.
Sex: M
Vaccine: FLU3
Symptoms: Productive cough
Clinical narrative: Case number PHHY2016US011505 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 603435) website on 18 Jan 2016. This report refers to a 37 year old male patient. Medical history and concomitant medication were not reported. The patient was vaccinated with AGRIFLU (batch number: 174084) intramuscularly in the left arm on 10 Oct 2015. On 16 Oct 2015 the patient experienced sore throat, body pain, nasal congestion, cough with expectoration, myalgia and headache. Outcome of the events was reported as complete recovery. Seriousness of the events was reported as non serious and causality was not reported.
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Generalised oedema, Peripheral swelling
Clinical narrative: Case number PHHY2016US009392, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 604904) website on 18 Jan 2016. This report refers to a 66 years old female patient. Past medical history included as sleep apnea. Current condition included as depression. Concomitant medications included SONATA, SYNTHROID, potassium (manufacturer unknown), ZYRTEC, ATIVAN, COREG, EFFEXOR, BUSPAR, ZANTAC, LASIX and ZYTIS (manufacturer unknown). The patient was vaccinated with AGRIFLU (batch number: not reported) on 01 Oct 2015. On 05 Oct 2015, the patient experienced all joints aching very bad, swelling of hands and most of entire body. The patient visited to the emergency room. The outcome of the events was reported as condition unchanged. The seriousness of the events was reported as non-serious. The causality of the events was not reported. Following an internal review done for the data received on 18 Jan 2016, the following significant correction was done: Event coding changed from swelling to generalized edema.
Age: 73.0
Sex: F
Vaccine: FLU3
Symptoms: Blood test, Headache, Rhinorrhoea
Clinical narrative: Case number PHHY2016US011552, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS reference number: 607341) website on 18 Jan 2016. This report refers to a 73 years old female patient. Past medical history included as hypercholesteraemia. Current condition included as non-insulin-dependent diabetes mellitus (NIDDM) (05 years) and hypertension. Concomitant medications included as TOPROL, K-DUR, glimepiride (manufacturer unknown), NORVASC, TRADJENTA, omeprazole (manufacturer unknown), allopurinol (manufacturer unknown), LIPITOR, CALTRATE, CENTRUM SILVER, metoprolol succinate (manufacturer unknown), OCUVITE, ALEVE, and OPTIVE. The patient was vaccinated with second dose of AGRIFLU (batch number: 1516001) into arm on 07 Oct 2015. On 13 Oct 2015, the patient experienced headaches (crown, occiput - Frontal) and runny nose. The patient blood drew on 04 Nov 2015. The outcome of the events was reported as unknown. The seriousness of the events was reported as non-serious. The causality of the events was not reported.
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Chills, Erythema, Headache, Injection site rash
Clinical narrative: Case number PHHY2016US013164, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS, reference number: 607807) on 18 Jan 2016. This report refers to a 50 years old female patient. Past vaccination history included abscess on forehead after nasal FLUMIST. Current conditions included hypertension, Prediabetes and allergy to Lisinopril VICODIN and Mountain Cedar. Concomitant medications included MICARDIS, hydrochlorothiazide (manufacturer unknown), iron (manufacturer unknown) CENTRUM MTV and vitamin D. She was vaccinated with second dose of AGRIFLU (batch number: 145903) intramuscularly into the right arm on 15 Oct 2014. After vaccination, on the same day, she experienced itching, redness, swelling, fever, chill, body aches in joints with a headache, small bumps developed around injection site which turned into sores that lasted up to two weeks. She received a treatment with antibiotic ointment on the site. The outcome of the events was reported as complete recovery on an unknown date.
Sex: F
Vaccine: FLU3
Symptoms: Injection site ulcer, Pruritus, Pyrexia, Swelling
Clinical narrative: Case number PHHY2016US013164, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS, reference number: 607807) on 18 Jan 2016. This report refers to a 50 years old female patient. Past vaccination history included abscess on forehead after nasal FLUMIST. Current conditions included hypertension, Prediabetes and allergy to Lisinopril VICODIN and Mountain Cedar. Concomitant medications included MICARDIS, hydrochlorothiazide (manufacturer unknown), iron (manufacturer unknown) CENTRUM MTV and vitamin D. She was vaccinated with second dose of AGRIFLU (batch number: 145903) intramuscularly into the right arm on 15 Oct 2014. After vaccination, on the same day, she experienced itching, redness, swelling, fever, chill, body aches in joints with a headache, small bumps developed around injection site which turned into sores that lasted up to two weeks. She received a treatment with antibiotic ointment on the site. The outcome of the events was reported as complete recovery on an unknown date.
Sex: U
Vaccine: FLUX
Symptoms: Alopecia, Insomnia, Mobility decreased, Pain
Clinical narrative: Case number PHHY2016US022444, is an initial spontaneous report received from a consumer via Vaccine Adverse Event Reporting System (VAERS, reference number: 610930) website on 19 Feb 2016. This report refers to a 63 years old patient of an unknown gender. Historical condition was not reported. Current conditions included multiple sclerosis, iodine allergy and drug allergy (MACRODANTIN). Concomitant medication was not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) on 27 Oct 2014. On an unknown date after vaccination, the patient experienced hurting all over, barley able to move, inability to sleep and hair thinning out. Corrective treatment and laboratory investigations were not reported. The outcome of the events was reported as unknown. Seriousness of the events was reported as non serious and causality not reported.
Sex: F
Vaccine: FLUX
Symptoms: Erythema, Local swelling, Oedema peripheral, Pain in extremity, Peripheral swelling
Clinical narrative: Case number PHHY2016US023293, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS, reference number: 61160) website on 19 Feb 2016. This report refers to a 91 years old female patient. Historical condition was not reported. Current conditions included allergy from medications, shots and bee sting. Concomitant medication included BENADRYL. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) 07 Oct 2015. On 10 Oct 2015, 03 days after vaccination, the patient experienced hives, red, itching, swelling around arm, in armpit and up left side of neck and pain in arms for 3 weeks afterward. The patient visited the emergency room on an unknown date. Final outcome of the events was reported as complete recovery. Seriousness of the events was reported as non serious and causality not reported.
Sex: F
Vaccine: FLUX
Symptoms: Pruritus, Urticaria
Clinical narrative: Case number PHHY2016US023293, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS, reference number: 61160) website on 19 Feb 2016. This report refers to a 91 years old female patient. Historical condition was not reported. Current conditions included allergy from medications, shots and bee sting. Concomitant medication included BENADRYL. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) 07 Oct 2015. On 10 Oct 2015, 03 days after vaccination, the patient experienced hives, red, itching, swelling around arm, in armpit and up left side of neck and pain in arms for 3 weeks afterward. The patient visited the emergency room on an unknown date. Final outcome of the events was reported as complete recovery. Seriousness of the events was reported as non serious and causality not reported.
Sex: F
Vaccine: FLUX
Symptoms: Pyrexia
Clinical narrative: Case number PHHY2016US023293, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 615555) on 19 Feb 2016. This report refers to a female patient of an unknown age. Medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on an unknown date. On an unknown date after vaccination the patient experienced fever. The outcome, seriousness and causality of the event were not reported.
Age: 21.0
Sex: U
Vaccine: FLUX
Symptoms: Chills, Pyrexia
Clinical narrative: Case number PHHY2016US023793, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS, reference number: 615755) website on 19 Feb 2016. This report refers to a 21 years old adult patient of an unknown gender. Past medical history and concomitant medication were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown and batch number: not reported) on an unknown date. After vaccination, the patient experienced fever and chills. The outcome, seriousness and causality of the events were not reported.
Sex: M
Vaccine: FLU3, PPV
Symptoms: Administration site inflammation, Injection site erythema, Mobility decreased
Clinical narrative: Case number PHHY2016US030845, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 617002) on 29 Feb 2016. This report refers to a 30 years old male patient. Medical history and concomitant medications were not reported. The patient was vaccinated with AGRIFLU (batch number: 174281) and PNEUMOVAX (batch number: L019836, other manufacturer); both intramuscularly into right arm on 28 Dec 2015. On 29 Dec 2015 the patient experienced redness and inflammation at administration site. Further the patient had difficulty to raise arm and redness gradually spread and became larger. The patient went for evaluation. The patient was advised to gentle stretch, apply cold pack and take MOTRIN. The case was assessed as non-serious. The outcome and causality of the events was not reported.
Sex: F
Vaccine: FLU3
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Case number PHHY2016US034626, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number:618813) website on 15 Mar 2016. This report refers to 21 years old female patient. Past medical history was not reported. Concomitant medication included JUNEL 1/20. She was vaccinated with AGRIFLU (batch number: 15755P), intramuscularly on left arm on 25 Nov 2015. On the same day, after vaccination she had severe arm aches/pain leading to trouble lifting arm up which continued for two months currently. She took two rounds of steroid dose packs to help to resolve some pain. On an unknown date, she went to emergency room. The final outcome of the events was reported as unknown. Seriousness of the events was reported as non serious and causality was not reported.
Sex: F
Vaccine: FLUX
Symptoms: Cough, Dyspnoea, Malaise, Nasopharyngitis, Nausea
Clinical narrative: Case number PHHY2016US039578, is an initial spontaneous report received from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 619147) on 18 Mar 2016. This report refers to a 76 years old female patient. Past medical history was not reported. Current conditions included chronic obstructive pulmonary disease and bronchitis. Concomitant medication included EFFEXOR. She was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) and started the course with ADVAIR diskus (batch number 5ZP1526, expiry: Feb 2017) for an unknown indication and on 18 Nov 2015. On 19 Nov 2015, she started ADVAIR diskus at a dose of 100/50ug. On 20 Nov 2015, 1 day after starting ADVAIR Diskus, she experienced device use error. The action taken with ADVAIR diskus was unknown. On an unknown date, the outcome of the device use error was unknown. On the morning of reporting, when she tried to use the device, she could not get it open. She was trying to flip the light purple section up to expose the mouthpiece. She had forgotten that the inhaler needed to be twisted to expose the mouthpiece. She attempted to us the product incorrectly. In Nov 2015 (date unspecified), she never felt good (malaise), at some point felt nauseated, wheezing and trouble breathing while walking. On 01 Dec 2015, 13 days after receiving the flu vaccine and ADVAIR diskus she experienced cold symptoms, sniffles and cough. She thought she had flu. The patient visited back the doctor, who confirmed that she did not have the flu, but sinusitis instead. She was prescribed and antibiotic. On 17 Dec 2015, she was still wheezing. It was unknown if the events were related to flu vaccination. She would talk to her doctor about talking ADVAIR twice per day instead of once per day, which has led to an underdose. The outcome of the events was reported as unknown. The events were assessed as non serious and causality were not reported.
Sex: F
Vaccine: FLUX
Symptoms: Rhinorrhoea, Sinusitis, Wheezing
Clinical narrative: Case number PHHY2016US039578, is an initial spontaneous report received from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 619147) on 18 Mar 2016. This report refers to a 76 years old female patient. Past medical history was not reported. Current conditions included chronic obstructive pulmonary disease and bronchitis. Concomitant medication included EFFEXOR. She was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) and started the course with ADVAIR diskus (batch number 5ZP1526, expiry: Feb 2017) for an unknown indication and on 18 Nov 2015. On 19 Nov 2015, she started ADVAIR diskus at a dose of 100/50ug. On 20 Nov 2015, 1 day after starting ADVAIR Diskus, she experienced device use error. The action taken with ADVAIR diskus was unknown. On an unknown date, the outcome of the device use error was unknown. On the morning of reporting, when she tried to use the device, she could not get it open. She was trying to flip the light purple section up to expose the mouthpiece. She had forgotten that the inhaler needed to be twisted to expose the mouthpiece. She attempted to us the product incorrectly. In Nov 2015 (date unspecified), she never felt good (malaise), at some point felt nauseated, wheezing and trouble breathing while walking. On 01 Dec 2015, 13 days after receiving the flu vaccine and ADVAIR diskus she experienced cold symptoms, sniffles and cough. She thought she had flu. The patient visited back the doctor, who confirmed that she did not have the flu, but sinusitis instead. She was prescribed and antibiotic. On 17 Dec 2015, she was still wheezing. It was unknown if the events were related to flu vaccination. She would talk to her doctor about talking ADVAIR twice per day instead of once per day, which has led to an underdose. The outcome of the events was reported as unknown. The events were assessed as non serious and causality were not reported.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Axillary pain, Hypoaesthesia, Injection site pain, Pain, Pain in extremity
Clinical narrative: Case number PHHY2016US042177, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 620457) website on 29 Mar 2016. This report refers to 48 years old female patient. Past medical history was not reported. Current conditions included heart disease and diabetes. Concomitant medications included LAMICTAL, HYAAR, glipizide (manufacturer unknown), metformin (manufacturer unknown), metoprolol (manufacturer unknown), Aspirin and melatonin (manufacturer unknown). She as vaccinated with AGRIFLU (batch number: 173537), intramuscularly on left arm on 25 Nov 2015. On same day, after receiving the flu shot she experienced pain in left shoulder and arm, with radiating pain to hand and fingers. There was constant ache located in left deltoid and mid arm, shooting pain down arm, aching pain under arm and sometime numbness and tingling throughout arm and fingers. There was pain behind shoulder, it hurt to use left arm and when use it, the pain increased. On an unknown date, she went to emergency room. On an unknown date, diagnostic examination and diagnostic evaluation was done and she underwent physical therapy. The final outcome of the events was not reported. The seriousness of the events was reported as non serious and causality was not reported.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Paraesthesia
Clinical narrative: Case number PHHY2016US042177, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 620457) website on 29 Mar 2016. This report refers to 48 years old female patient. Past medical history was not reported. Current conditions included heart disease and diabetes. Concomitant medications included LAMICTAL, HYAAR, glipizide (manufacturer unknown), metformin (manufacturer unknown), metoprolol (manufacturer unknown), Aspirin and melatonin (manufacturer unknown). She as vaccinated with AGRIFLU (batch number: 173537), intramuscularly on left arm on 25 Nov 2015. On same day, after receiving the flu shot she experienced pain in left shoulder and arm, with radiating pain to hand and fingers. There was constant ache located in left deltoid and mid arm, shooting pain down arm, aching pain under arm and sometime numbness and tingling throughout arm and fingers. There was pain behind shoulder, it hurt to use left arm and when use it, the pain increased. On an unknown date, she went to emergency room. On an unknown date, diagnostic examination and diagnostic evaluation was done and she underwent physical therapy. The final outcome of the events was not reported. The seriousness of the events was reported as non serious and causality was not reported.
Sex: F
Vaccine: FLUX
Symptoms: Gastroenteritis viral
Clinical narrative: Case number PHHY2016US056454 is an initial spontaneous report received form the Vaccine Adverse Event Reporting System (VAERS reference number: 626846) on 18 Apr 2016. This report refers to a 67 year old female patient. Medical history and concomitant medication was not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on an unknown start date. On an unknown date the patient experienced stomach and intestinal flu symptoms. The outcome of the events was not reported. Seriousness and causality of the events was unknown.
Sex: F
Vaccine: FLUX
Symptoms: Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: Case number PHHY2016US115311 is an initial spontaneous case received from other healthcare professional via Vaccine Adverse Event Reporting System (VAERS reference number: 635420) website on 23 Aug 2016. This report refers to 61 year old female patient. The patient medical history and concomitant medication was not reported. The patient was vaccinated with seasonal influenza virus vaccine (manufacturer: unknown, batch number: not reported) on an unspecified date. On an unknown date, the patient experienced red, painful swollen arm. The outcome, seriousness and causality of events was not reported.
Sex: F
Vaccine: FLUX
Symptoms: Axillary pain, Lymphadenopathy, Malaise, Mobility decreased, Neck pain
Clinical narrative: Case number PHHY2016US105713, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 637760). This report refers to a 38 year old female patient (reported as 38.5). Medical history and Concomitant medications were not reported. The patient was vaccinated with Influenza Virus seasonal vaccine (manufacturer unknown, batch number: not reported) on an unknown date in 2014 in the right arm. About a week after vaccination, the patient experienced malaise, low grade fever, pain under her right arm, in the neck and the clavicular area. She noticed several pea sized swollen lymph nodes in the clavicular are and neck. She could hardly raise her right arm and it was painful to turn her neck. The reactions were not as severe. The symptoms lasted about 2 weeks. In Jan 2015, she did have the flu. Final outcome of the events was reported as unknown. Seriousness of the events was reported as non serious. Causality of the events was not reported.
Sex: F
Vaccine: FLUX
Symptoms: Pain, Pyrexia
Clinical narrative: Case number PHHY2016US105713, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 637760). This report refers to a 38 year old female patient (reported as 38.5). Medical history and Concomitant medications were not reported. The patient was vaccinated with Influenza Virus seasonal vaccine (manufacturer unknown, batch number: not reported) on an unknown date in 2014 in the right arm. About a week after vaccination, the patient experienced malaise, low grade fever, pain under her right arm, in the neck and the clavicular area. She noticed several pea sized swollen lymph nodes in the clavicular are and neck. She could hardly raise her right arm and it was painful to turn her neck. The reactions were not as severe. The symptoms lasted about 2 weeks. In Jan 2015, she did have the flu. Final outcome of the events was reported as unknown. Seriousness of the events was reported as non serious. Causality of the events was not reported.
Sex: F
Vaccine: FLUX
Symptoms: Immediate post-injection reaction, Rash
Clinical narrative: Case number PHHY2016US161428, is an initial spontaneous report received from a consumer (patient's mother) via Vaccine Adverse Event Reporting System (VAERS reference number: 643901) on 21 Nov 2016. This report refers to a female patient of unknown age. Medical history was not reported. Current condition included craniosynostosis. Concomitant medication was not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on an unknown date in 2014. The patient experienced rash immediately after the injection. It was reported that she didn't experience anaphylaxis. The outcome of the event was not reported. The seriousness and causality of the event was not reported.
Sex: U
Vaccine: FLUX
Symptoms: Burning sensation
Clinical narrative: Case number PHHY2016US159349, is an initial spontaneous report received from a consumer via the Vaccine Adverse Event Reporting System (VAERS reference number: 645986) website on 21 Nov 2016. This report refers to a patient of unknown age and gender. Past medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine inn (manufacturer unknown and batch number: not reported) on an unknown date. On an unknown date, the patient had burns for couple of days. The outcome of the event was reported as condition unchanged. The seriousness and causality of the event were not reported.
Age: 30.0
Sex: F
Vaccine: FLUX
Symptoms: Arthralgia, Chest discomfort, Injection site hypersensitivity
Clinical narrative: Case number PHHY2016US162499, is an initial spontaneous report received from a physician via vaccine adverse event reporting system (VAERS reference number: 646247) web site on 21 Nov 2016. This report refers to a 30 years old female patient. Medical history and concomitant medication were not reported. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer unknown, batch number was not reported) from an unknown start date. Following the vaccination, the patient experienced pain in her joint, a heavy feeling in her chest and local allergic reaction at the site, on an unknown date. It was reported that the physician planned to give some steroids (unspecified) and pain medication (unspecified) as a corrective treatment. The patient also required an emergency room (ER/physician visit). The outcome of the events was reported as condition unchanged (not recovered). The seriousness and causality assessment of the events were not reported.
Sex: U
Vaccine: FLUX
Symptoms: Malaise
Clinical narrative: Case number PHHY2016US162598, is an initial spontaneous report received from a consumer (patient) via Vaccine Adverse Event Reporting System (VAERS reference number: 646287) web site on 21 Nov 2016. This report refers to a patient of an unknown age and gender. Medical history and concomitant medication were not reported. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer unknown, batch number: not reported) on an unknown date. The patient felt sick after taking a dose of the vaccine previously. The patient was about to take a decision if it was safe to try it again and then would seek that out. The outcome for the event felt sick was condition unchanged (not recovered). The seriousness and causality assessment of the event felt sick were not reported.
Sex: F
Vaccine: FLUX
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: Case number PHHY2016US162482, is an initial spontaneous report received from a consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 646693) website on 21 Nov 2016. This report refers to a female patient of an unknown age. Medical history and concomitant medication were not reported. The patient was vaccinated with seasonal influenza virus vaccine INN (unknown manufacturer, batch number: not reported) on an unknown date (reported as several weeks ago), at an unknown dose, frequency and route. On an unknown date after vaccination, the patient had pain in arm and elbow. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported.
Age: 66.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Chills, Headache, Hyperhidrosis, Hypophagia, Injection site erythema
Clinical narrative: Case number PHHY2016US161407, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 649079) website on 21 Nov 2016. This report refers to a 66 years old female patient. Past medical history was not reported. Current condition included as bedridden for two days. Concomitant medications included as amlodipine, valsartan and hydrochlorothiazide, LIPITOR, calcium citrate, aspirin, Vitamin D, multi-vitamin, nitrofurantoin. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer and batch number: not reported) into left arm, intramuscularly and pneumococcal vaccine (other manufacture, batch number: not reported) (reported as pneumo vaccine) into right arm, intramuscularly, both on 16 Aug 2016. On 17 Aug 2016, the patient experienced chills, fever, severe headache, nausea, severe body aches, injection site soreness, at injection site 12 by 4 bright red inflamed area and sweats. The patient had no food or water intake for 24 hours. The patient visited the emergency room on an unspecified date. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 66.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Injection site inflammation, Injection site pain, Nausea, Pain, Pyrexia
Clinical narrative: Case number PHHY2016US161407, is an initial spontaneous report received from a Vaccine Adverse Event Reporting System (VAERS reference number: 649079) website on 21 Nov 2016. This report refers to a 66 years old female patient. Past medical history was not reported. Current condition included as bedridden for two days. Concomitant medications included as amlodipine, valsartan and hydrochlorothiazide, LIPITOR, calcium citrate, aspirin, Vitamin D, multi-vitamin, nitrofurantoin. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer and batch number: not reported) into left arm, intramuscularly and pneumococcal vaccine (other manufacture, batch number: not reported) (reported as pneumo vaccine) into right arm, intramuscularly, both on 16 Aug 2016. On 17 Aug 2016, the patient experienced chills, fever, severe headache, nausea, severe body aches, injection site soreness, at injection site 12 by 4 bright red inflamed area and sweats. The patient had no food or water intake for 24 hours. The patient visited the emergency room on an unspecified date. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 24.0
Sex: F
Vaccine: FLUX
Symptoms: Pyrexia
Clinical narrative: Case number PHHY2016US161388 is an initial spontaneous report received via Vaccine Adverse Events Reporting System  (VAERS reference number: 650609) on 21 Nov 2016. This report refers to a 24 year old female patient. Her medical history and concomitant medications were not reported was not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on an unknown date. On an unspecified date after vaccination, she experienced fever. The outcome, seriousness and causality of the events was not reported. The patient further received a dose of seasonal influenza vaccine (manufacturer and batch number: not reported) on 01 Sep 2012 following which she experienced dermatofibroma at the injection site (see related case number: PHHY2016US161386). No further information was provided.
Sex: F
Vaccine: FLUX, HEPAB
Symptoms: Hypopnoea, Urticaria
Clinical narrative: Case number PHHY2016US161434, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 650610) website on 21 Nov 2016. This report refers to a 37-years-old female patient. Past medical history was not reported. Current condition included allergy to penicillin. Concomitant medications included iron. The patient was vaccinated with seasonal influenza virus vaccine INN (unknown manufacturer, batch number: not reported) intramuscularly in right arm on 01 Sep 2016. The patient also vaccinated with HEPAB intramuscularly in right arm 01 Sep 2016. On the same day after vaccination, the patient experienced hives on chest and slight and shallow breathing. The outcome of the events hives on chest and slight shallow breathing was reported as condition unchanged. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: F
Vaccine: FLUX, PPV
Symptoms: Activities of daily living impaired, Altered state of consciousness, Arthralgia, Asthenia, Axillary pain
Clinical narrative: Case number PHHY2016US160840, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 651384) website on 21 Nov 2016. This report refers to a 39 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer and batch number: not reported) into left arm on 06 Sep 2016. The patient also vaccinated with pneumococcal vaccine (other manufacture, batch number: not reported) (reported as pneumo vaccine) on 06 Sep 2016. It was reported that, patient while at work on 03 occasions between 04:00 pm and 09:00 pm (on 06 Sep 2016), got really warm and felt like she was going to pass out. That same night patient went to bed and woke up in a complete sweat had a headache and low grade fever. The next morning patient woke up and her muscles and joints hurt, nausea, low grade fever, dizzy and felt disoriented and not to mention, the left arm was so painful and her armpit was extremely sore. Patient called the clinic and spoke with her physician nurse and she excused her from work because patient was incapable of going and she rested all day Wed. The patient took a lot of Ibuprofen which did not help the fever or pain for very long. The patient had absolutely no appetite and did her best at keeping hydrated. On Wed night patient woke up a few times drenched in sweat that she had to wash her pillow and bedding. The patient could not afford to miss another day, so Thurs she went to work. It was completely rough as she work in healthcare. The patient was in a sweat her entire 08 hours and was dizzy, weak and nauseous as well as leg achiness and feeling of being shocked. The patient forgot to mention she did call facility back and talked to her physician nurse and she said patient had an allergic reaction to the pneumonia vaccine. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: F
Vaccine: FLUX, PPV
Symptoms: Decreased appetite, Disorientation, Dizziness, Feeling hot, Headache
Clinical narrative: Case number PHHY2016US160840, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 651384) website on 21 Nov 2016. This report refers to a 39 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer and batch number: not reported) into left arm on 06 Sep 2016. The patient also vaccinated with pneumococcal vaccine (other manufacture, batch number: not reported) (reported as pneumo vaccine) on 06 Sep 2016. It was reported that, patient while at work on 03 occasions between 04:00 pm and 09:00 pm (on 06 Sep 2016), got really warm and felt like she was going to pass out. That same night patient went to bed and woke up in a complete sweat had a headache and low grade fever. The next morning patient woke up and her muscles and joints hurt, nausea, low grade fever, dizzy and felt disoriented and not to mention, the left arm was so painful and her armpit was extremely sore. Patient called the clinic and spoke with her physician nurse and she excused her from work because patient was incapable of going and she rested all day Wed. The patient took a lot of Ibuprofen which did not help the fever or pain for very long. The patient had absolutely no appetite and did her best at keeping hydrated. On Wed night patient woke up a few times drenched in sweat that she had to wash her pillow and bedding. The patient could not afford to miss another day, so Thurs she went to work. It was completely rough as she work in healthcare. The patient was in a sweat her entire 08 hours and was dizzy, weak and nauseous as well as leg achiness and feeling of being shocked. The patient forgot to mention she did call facility back and talked to her physician nurse and she said patient had an allergic reaction to the pneumonia vaccine. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: F
Vaccine: FLUX, PPV
Symptoms: Hypersensitivity, Myalgia, Nausea, Night sweats, Pain in extremity
Clinical narrative: Case number PHHY2016US160840, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 651384) website on 21 Nov 2016. This report refers to a 39 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine INN (manufacturer and batch number: not reported) into left arm on 06 Sep 2016. The patient also vaccinated with pneumococcal vaccine (other manufacture, batch number: not reported) (reported as pneumo vaccine) on 06 Sep 2016. It was reported that, patient while at work on 03 occasions between 04:00 pm and 09:00 pm (on 06 Sep 2016), got really warm and felt like she was going to pass out. That same night patient went to bed and woke up in a complete sweat had a headache and low grade fever. The next morning patient woke up and her muscles and joints hurt, nausea, low grade fever, dizzy and felt disoriented and not to mention, the left arm was so painful and her armpit was extremely sore. Patient called the clinic and spoke with her physician nurse and she excused her from work because patient was incapable of going and she rested all day Wed. The patient took a lot of Ibuprofen which did not help the fever or pain for very long. The patient had absolutely no appetite and did her best at keeping hydrated. On Wed night patient woke up a few times drenched in sweat that she had to wash her pillow and bedding. The patient could not afford to miss another day, so Thurs she went to work. It was completely rough as she work in healthcare. The patient was in a sweat her entire 08 hours and was dizzy, weak and nauseous as well as leg achiness and feeling of being shocked. The patient forgot to mention she did call facility back and talked to her physician nurse and she said patient had an allergic reaction to the pneumonia vaccine. The outcome of the events was reported as complete recovery on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.